lenalidomide has been researched along with Liver Failure, Acute in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Q; Gong, Z; Jiao, F; Lv, J; Pei, M; Shi, C; Wang, L; Wang, Y; Zhang, H | 1 |
Jain, P | 1 |
1 review(s) available for lenalidomide and Liver Failure, Acute
Article | Year |
---|---|
Lenalidomide-induced acute liver failure.
Topics: Adenine; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Hepatitis B, Chronic; Humans; Lenalidomide; Liver Failure, Acute; Male; Myelodysplastic Syndromes; Organophosphonates; Thalidomide | 2009 |
1 other study(ies) available for lenalidomide and Liver Failure, Acute
Article | Year |
---|---|
TNF-α/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury.
Topics: Acute Kidney Injury; Animals; Cell Differentiation; Glycyrrhizic Acid; HMGB1 Protein; Humans; Inflammation; Lenalidomide; Liver Failure, Acute; Macrophages; Male; Mice, Inbred C57BL; Polymorphism, Single Nucleotide; Pyroptosis; Signal Transduction; THP-1 Cells; Tumor Necrosis Factor-alpha | 2020 |